These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 152493)

  • 1. Patterns of immune response in well tolerated renal grafts.
    Renna E; Pelle M; Nesci C; Alfani D; Cortesini R
    Transplant Proc; 1978 Sep; 10(3):595-8. PubMed ID: 152493
    [No Abstract]   [Full Text] [Related]  

  • 2. Influence of blood transfusions on immune responsiveness.
    Kerman RH; Van Buren CT; Payne W; Flechner S; Agostino G; Conley S; Brewer E; Kahan BD
    Transplant Proc; 1982 Jun; 14(2):335-7. PubMed ID: 6214061
    [No Abstract]   [Full Text] [Related]  

  • 3. [Immunological diagnosis of the kidney allograft rejection reaction].
    Drannik GN
    Urol Nefrol (Mosk); 1981; (5):64-71. PubMed ID: 6458144
    [No Abstract]   [Full Text] [Related]  

  • 4. The in vitro assessment of the immunosuppressive effect of fractionated total lymphoid irradiation in renal allotransplantation.
    Ferguson RM; Sutherland DE; Kim T; Simmons RL; Najarian JS
    Transplant Proc; 1981 Sep; 13(3):1673-5. PubMed ID: 6458136
    [No Abstract]   [Full Text] [Related]  

  • 5. [Immunity and hypersensitivity in Hodgkin's lymphoma].
    Leoni P; Marchegiani G; Montillo M; Centurioni R; Montroni M; Danieli G
    Minerva Med; 1982 May; 73(20):1361-9. PubMed ID: 6210855
    [No Abstract]   [Full Text] [Related]  

  • 6. Antibody modulation of cellular reactivity post renal transplantation.
    Garovoy MR; Phillips SM; Carpenter CB; Merrill JP
    Transplant Proc; 1973 Mar; 5(1):129-32. PubMed ID: 4266650
    [No Abstract]   [Full Text] [Related]  

  • 7. Pre-transplantation immunological monitoring and graft survival in recipients of renal allografts.
    Middleton D; Sleator C; McNeill TA; Merrett JD; Douglas JF; McGeown MG
    Clin Nephrol; 1984 Apr; 21(4):223-9. PubMed ID: 6375925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transplantation in miniature swine. VII. Evidence for cellular immune mechanisms in hyperacute rejection of renal alografts.
    Kirkman RL; Colvin RB; Flye MW; Williams GM; Sachs DH
    Transplantation; 1979 Jul; 28(1):24-30. PubMed ID: 156420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of blood transfusion on immune responses and their relationship to renal allograft survival.
    Goeken NE; Flanigan MJ; Thompson JS; Corry RJ; Nghiem DD; Rhoades JL; Evans GA; Melton ZJ
    Transplant Proc; 1982 Jun; 14(2):338-40. PubMed ID: 6214062
    [No Abstract]   [Full Text] [Related]  

  • 10. Maintenance of cytomegalovirus (CMV) latency and host immune responses of long term renal allograft survivors. II. Secondary CMV infections associated with impaired in vitro proliferative responses to mitogens, allogeneic lymphocytes and CMV infected cells.
    Roenhorst HW; Beelen JM; Middeldorp JM; Schirm J; Tegzess AM; The TH
    Clin Exp Immunol; 1985 Jul; 61(1):72-9. PubMed ID: 2994923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of the fetal immune system.
    Siegel I; Gleicher N
    Prog Clin Biol Res; 1981; 70():31-40. PubMed ID: 6458824
    [No Abstract]   [Full Text] [Related]  

  • 12. The HL-A complex in kidney transplantation.
    Dausset J
    Clin Nephrol; 1974; 2(1):1-3. PubMed ID: 4274665
    [No Abstract]   [Full Text] [Related]  

  • 13. Humoral inhibitors of the immune response in uremia. IV. Effects of serum and of isolated serum very low density lipoprotein from uremic rats on cellular immune reactions in vitro.
    Raskova J; Raska K
    Lab Invest; 1981 Nov; 45(5):410-7. PubMed ID: 6457930
    [No Abstract]   [Full Text] [Related]  

  • 14. [Cell-mediated immunoreactivity in patients with chronic kidney insufficiency].
    Lenhard V; Manke HG; Rother U; Röckel A; Ritz E
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():834-7. PubMed ID: 148187
    [No Abstract]   [Full Text] [Related]  

  • 15. [Some parameters of cellular immunity in renal transplantation after more than three years].
    Di Padova F; Morandi E; Baldini L; Vallino F; Como G; Celega E
    Boll Ist Sieroter Milan; 1979 Jan; 57(6):765-73. PubMed ID: 399731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of the active thymus derived rosette forming cells in renal allograft survival: a preliminary report.
    Kerman RH; Ing TS; Hano JE; Geis WP
    Surgery; 1977 Nov; 82(5):607-12. PubMed ID: 335551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Donor-specific decreased primary and secondary cell-mediated immune responses in patients with well functioning grafts.
    Pfeffer PF; Hirschberg H; Thorsby E
    Transplant Proc; 1981 Sep; 13(3):1604-6. PubMed ID: 6458131
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunologic monitoring of the renal transplant recipient.
    Suthanthiran M; Garovoy MR
    Urol Clin North Am; 1983 May; 10(2):315-25. PubMed ID: 6222530
    [No Abstract]   [Full Text] [Related]  

  • 19. Cellular function and T cell subsets in patients with long-surviving renal transplants.
    Bakran A; Taylor GM; Read I; Johnson RW; Harris R
    Transplant Proc; 1984 Dec; 16(6):1558-60. PubMed ID: 6239425
    [No Abstract]   [Full Text] [Related]  

  • 20. Suppression and stimulation of T cell clones of renal transplant recipients by autologous post-transplant sera: a role for regulatory antibodies.
    Daniel V; Opelz G
    Transplant Proc; 1987 Oct; 19(5):4210-3. PubMed ID: 2960049
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.